Clinical Trials in San Diego

Showing 2901-2920 of 7,028 trials

Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

NCT02844933

The primary objective of this study is to assess the efficacy of cannabidiol oral solution on hyperphagia-related behavior in patients with Prader-Willi Syndrome (PWS). The secondary objectives of this study are to assess the efficacy, safety and tolerability, impact on quality of life, and impact on physical activity of cannabidiol oral solution in patients with PWS.

Prader-Willi Syndrome

Radius Pharmaceuticals, Inc.7 participantsStarted May 2018

Tucson, Arizona, United States • San Diego, California, United States • Iowa City, Iowa, United States +4 more locations

COMPLETEDPhase 3< 1 mile

A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

NCT02694978

To evaluate the safety of 1.020 grams (g) of intravenous (IV) ferumoxytol compared to 1.500 g of IV ferric carboxymaltose (FCM).

Iron Deficiency Anemia

AMAG Pharmaceuticals, Inc.2,014 participantsStarted Feb 2016

Huntsville, Alabama, United States • Tucson, Arizona, United States • Tucson, Arizona, United States +124 more locations

Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

Find Trials by Condition in San Diego

Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis

A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)

Predicting Chronic Pain Following Breast Surgery

Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)

A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation

Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG

ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)

Look AHEAD: Action for Health in Diabetes

A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines

FreeStyle Libre 3 Continuous Glucose Monitoring System

A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

Family Health History in Diverse Care Settings (FHH)

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks